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Abstract
Introduction: Lung cancer is one of the greatest challenges for modern medicine and in Poland the incidence and mortality rate 
are one of the highest. 
The aim of the study was to assess trends in the incidence and mortality rate lung cancer in the Podkarpackie province in the 
years 2002−2011. 
Material and methods: 9993 cases (8018 men and 1975 women) and 8782 deaths (7211 men and 1571 women) of lung cancer 
were analyzed. Crude rate and standardized coefficients of incidence and mortality as well as stratum weight, and cumulative 
risk of incidence and mortality were calculated. 
Results: In 2011, in Podkarpackie province a decrease number of lung cancer cases in men was observed compared to 2002 
amounting to 195 case, but in women, an increase of 39 new cases was noted. Incidence rates in men were in the range 
of 65.8−93.1/100 000, while in women they ranged 9.6−35.2/100 000. Mortality rates for males ranged from 59.2 to 82.8/100 000, 
and in women from 6.1 to 29.0/100 000. Considerable diversity in incidence and mortality in different districts of the province 
of Podkarpackie was observed.
Conclusions: In the years 2002−2011 the values of incidence and mortality rates for men in Podkarpackie province were lower 
than the rates for Poland, in case of women the same rates for Podkarpackie were almost two times lower than the rates for 
Poland. In the years 2002−2011 the highest value of incidence and mortality rate out of all districts of Podkarpackie Province 
was observed in the district Lubaczów for men and in Przemyśl in case of women.
Key words: lung cancer, incidence rate, mortality rate
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Streszczenie
Wstęp: Rak płuca jest jednym z największych wyzwań współczesnej medycyny, a Polska należy do krajów o największej zapa-
dalności i umieralności z powodu tego nowotworu. 
Celem pracy była ocena trendów zachorowalności i umieralności na raka płuca w województwie podkarpackim w latach 2002−2011. 
Materiał i metody: Analizie poddano 9993 zachorowań (8018 u mężczyzn i 1975 u kobiet) i 8782 zgonów (7211 u mężczyzn 
i 1571 u kobiet) z powodu raka płuca. Zostały obliczone współczynniki surowe i standaryzowane zachorowalności i umieralności, 
wskaźniki struktury oraz ryzyko skumulowane zachorowania i zgonu. 
Wyniki: W 2011 roku w województwie podkarpackim zanotowano w porównaniu z  rokiem 2002 spadek liczby zachorowań 
u mężczyzn o 195 nowych przypadków, natomiast u kobiet nastąpił wzrost o 39 nowych zachorowań. Współczynniki zachorowal-
ności u mężczyzn wahały się w przedziale 65,8−93,1/100 000, natomiast u kobiet w przedziale 9,6–35,2/100 000. Współczynniki 
umieralności dla mężczyzn wynosiły od 59,2 do 82,8/100 000, a u kobiet od 6,1 do 29,0/100 000. 
Zaobserwowano duże zróżnicowanie zachorowalności i umieralności w poszczególnych powiatach województwa podkarpackiego. 
Wnioski: W latach 2002−2011 w województwie podkarpackim współczynniki zachorowalności i umieralności dla mężczyzn 
przyjmowały wartości niższe niż współczynniki w tym samym czasie dla Polski, a u kobiet te same współczynniki dla wojewódz-
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twa podkarpackiego przyjmowały wartości prawie dwukrotnie niższe niż wartości współczynników dla Polski. W powiatach 
województwa podkarpackiego w  latach 2002−2011 największą wartość współczynnika zachorowalności i  umieralności dla 
mężczyzn zaobserwowano w powiecie lubaczowskim, a u kobiet w mieście Przemyślu. 
Słowa kluczowe: rak płuca, zachorowalność, umieralność
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Introduction
Lung cancer is one of the biggest challenges 
for contemporary medicine. It affects epidemi-
ological, diagnostic and therapeutic issues [1]. 
According to estimated data prepared by the IARC 
(International Agency for Research on Cancer) in 
2012, there were approximately 1.8 million new 
registered cases of lung cancer incidence, and 
58% of them concerned less developed countries. 
The highest incidence among men (1.2 million) 
was noted in Central and Eastern Europe and East-
ern Asia. Particularly low incidence rates were ob-
served in Central (2.0/100 000) and Western Africa 
(1.7/100 000). Among women, the highest inci-
dence was noted in North America (33.8/100 000), 
Northern Europe (23.7/100 000) and Eastern Asia 
(19.2/100 000). The lowest incidence among wom-
en was observed in West Africa and Middle East 
(1.1/100 000 and 0.8/100 000 respectively) [2]. 
Lung cancer is the most frequent cause of cancer 
deaths worldwide. Estimated data indicate that 
in 2012, there were approximately 1.6 million 
deaths and lung cancer constituted 19.4% among 
all cancers [3]. While comparing incidence and 
mortality worldwide, it can be noticed that the 
highest incidence and mortality occur in the same 
regions of the world. 
Poland belongs to the countries with the 
highest standardised ratio, both of incidence 
(33.4/100 000) and mortality (38.0/100 000). In 
Europe, higher coefficients belong only to Serbia 
(incidence — 39.1/100 000 and mortality — 
45.6/100 000), and Hungary (43.3/100 000 and 
51.6/100 000 respectively) [2]. About 20 000 
new cases and 22 000 deaths due to lung cancer 
are registered in Poland every year (Tables 1, 2). 
Over the discussed decade, the incidence rate 
increased in total by 6.4%, including the de-
crease in men by 4.3% and increase in women 
by as much as 43.4%. The decrease was also 
noted in respect to crude and standardised 
rates in men — respectively 81.9/100 000 and 
63.0/100 000 in 2002, and 77.9/100 000 and 
50.0/100 000 in 2011. Whereas in women, the 
rates increased markedly, and in 2002 crude and 
standardised rates reached the value of 22.2/100 
000 and 13.8/100 000 respectively, and in 2011, 
they amounted to 31.6/100 000 and 17.3/100 
000 (Table 1).
Table 1. Registered new cancer cases and lung cancer incidence in Poland between 2002−2011 [4]
Incidence males Year Incidence females
Registered 
new cancer 
cases
Crude rate 
per 100 000
Standardized 
rate
Cumulative 
risk %
Registered 
new cancer 
cases 
Crude rate 
per 100 000
Standardized 
rate
Cumulative 
risk %
149852 2002−2011 52433
15173 81.9 63.0 8.0 2002 4380 22.2 13.8 1.7
15762 85.2 64.1 8.1 2003 4781 24.3 14.8 1.8
15704 85.0 62.9 7.9 2004 4610 23.4 13.9 1.7
15248 82.6 60.0 7.6 2005 4797 24.4 14.4 1.8
15157 82.2 58.5 7.4 2006 5075 25.8 15.1 1.8
14659 79.6 55.4 7.0 2007 5250 26.7 15.5 1.9
14130 76.8 52.2 6.6 2008 5319 27.0 15.4 1.9
14703 79.8 53.3 6.8 2009 5900 29.9 16.7 2.1
14794 79.3 52.2 6.7 2010 6038 30.4 16.9 2.2
14522 77.9 50.0 6.4 2011 6283 31.6 17.3 2.2
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In Poland, different trends in lung cancer in-
cidence for men and women have been observed. 
After 2003, a significant decrease in crude and 
standardised incidence rates has been observed 
in men. Whereas in women, after 2004, rates have 
been on the increase (Table 1, Fig. 1).
Lung cancer is the first cause of all cancer 
deaths, both in men and women. In men, it consti-
tutes approximately 31% of all deaths due to can-
cer, whereas in women, about 16%. In men, the 
number of deaths decreased by 728 cases (4.4%). 
A downward trend is also reflected by crude and 
standardised mortality rates. Crude rates amount-
ed to 90.1/100 000 in 2002, and to 85.6/100 000 
in 2011, and standardised rates reached 68.6/100 
000 and 54.1/100 000 respectively. Whereas in 
women, an upward trend has been observed. 
Figure 1. Lung cancer incidence in Poland between 2002−2011, 
standardised rates
In 2002, crude and standardised mortality rates 
amounted to 22.9/100 000 and 13.6/100 000 
respectively, and in 2011, to 31.5/100 000 and 
16.2/100 000 (Table 2).
The most known risk factor of lung cancer is 
tobacco smoking. It is believed that over 90% of 
cases is related to carcinogenic effect of tobacco 
smoke. It is estimated that currently, 29% of 
adults, i.e. approximately 9 million Poles smoke 
cigarettes [5]. It has been proved that increased 
cigarette smoking brings closer the risk of lung 
cancer incidence on average by 20–30 years, and 
that tobacco smokers constitute 91% in men and 
approximately 70% in women suffering from lung 
cancer [6]. In recent years, a significant increase 
in incidence among women has been noted, 
which is related to the number of the cigarettes 
smoked. Passive smoking also poses a serious 
social problem. According to the WHO and the 
Ministry of Health, 19% of non-smoking Poles 
(24% of men and 14% of women) are exposed 
to tobacco smoke in their workplace. At home, 
passive smoking affects 25% of inhabitants of 
Poland (20% of non-smoking men and 29% of 
non-smoking women) [7].
It is believed that occupational exposure 
to carcinogenic factors is responsible for about 
9–15% of new diagnoses of lung cancer. The 
factors that determine the occurrence of the dis-
ease are asbestos and ionizing radiation [8, 9]. 
Inhaling asbestos dust may cause lung cancer 
and mesothelioma of the pleura [8]. Occupational 
conditions that raise the risk of lung cancer occur-
rence also include long-lasting exposure to diesel 
Table 2. Lung cancer mortality in Poland between 2002−2011 [4]
Death males Year Death females
Death Crude rate 
per 100 000
Standardized 
rate
Cumulative 
risk %
Death Crude rate 
per 100 000
Standardized 
rate
Cumulative 
risk %
164571 2002−2011 53411
16689 90.1 68.6 8.6 2002 4519 22.9 13.6 1.6
16301 88.2 66.0 8.3 2003 4688 23.8 13.9 1.7
16523 89.4 65.5 8.3 2004 4627 23.5 13.4 1.6
16522 89.5 64.4 8.1 2005 4933 25.0 14.2 1.7
16623 90.2 63.6 8.0 2006 5108 25.9 14.5 1.8
16556 89.9 61.7 7.8 2007 5552 28.2 15.5 1.9
16855 91.6 61.4 7.6 2008 5623 28.5 15.5 1.9
16354 88.8 58.3 7.3 2009 5945 30.1 16.0 2.0
16187 86.8 56.2 7.0 2010 6161 31.0 16.3 2.1
15961 85.6 54.1 6.7 2011 6255 31.5 16.2 2.1
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emissions and chemical factors accompanying the 
manufacture of rubber tyres. In 1982, the IARC 
recognised rubber industry as carcinogenic to 
humans [10]. It is believed that air pollution, in-
cluding polycyclic aromatic hydrocarbons and its 
derivatives induce approximately 1−2% of lung 
cancer cases annually. The studies conducted in 
the 1980s showed disadvantageous influence of 
saturated fat-rich diet, alcohol abuse and excessive 
beta-carotene supplementation on lung cancer 
development [11].
Primary prevention, i.e. combatting tobacco 
consumption is the most crucial tool to fight lung 
cancer incidence and mortality. It allows to un-
dertake activities that may prevent lung cancer 
occurrence. In Poland, since 2006 the Program 
on Primary Prevention being the part of the Na-
tional Program Against Cancer Diseases has been 
implemented. The program is fulfilled through 
regional Primary Prevention Offices, which have 
undertaken various activities aiming to promote 
pro-health education in the medical settings 
and socio-occupational groups (medical univer-
sities, social organisations, adults, children and 
youngsters). The effects of these activities include 
consolidation of healthy lifestyle patterns and 
prevention of unfavourable behaviour towards 
healthy persons [7]. Secondary prevention, i.e. 
preventive examinations of healthy individuals 
who belong to a high risk group, is the second 
most important tool that allows to detect lung 
cancer at early stage of development. The first 
screening test for early detection of lung cancer 
began in 1957 in Czechoslovakia. It consisted 
of radiological and cytological examinations 
performed every 6 months in smoking men aged 
40–64 [12]. The researches carried out in the 
1960s and 1970s (Memorial Sloan Kettering Lung 
Project, Johns Hopkins Lung Project, The Mayo 
Lung Program) also based on radiological and 
cytological examinations. They differed only in 
age of the subjects and the frequency of examina-
tions [13]. But these measures turned out to be 
ineffective in early detection of the disease [14].
New possibilities appeared together with 
introduction of spiral computed tomography. 
It is very sensitive examination that uses a low 
exposure dose, therefore it is acceptable in terms 
of radiological protection and safety of screening 
test [13]. Since 1992 the studies on the use of low-
dose computed tomography (LDCT), which is an 
efficient tool for screening among long-term ha-
bitual tobacco smokers have been conducted [15]. 
In Poland, pilot studies have been already carried 
out in Szczecin, Gdańsk and Warsaw, where in 
total more than 30,000 persons from high risk 
groups have been examined. The results of the 
studies have shown explicitly an increased detec-
tion of lung cancer at early stage of development, 
whereas no impact of the examination was found 
on the decrease in mortality [13, 16].
The objective of the study was to analyse 
incidence and mortality of malignant lung cancer 
in women and men in the Podkarpackie province 
in the years 2002−2011. 
Material and methods
Material for the study was obtained from the 
Podkarpackie Cancer Registry in Rzeszów.
Epidemiological analysis concerned 9993 
cases (8018 men and 1975 women) and 8782 
deaths (7211 men and 1571 women) due to malig-
nant lung cancer in the Podkarpackie province in 
the years 2002−2011. The following indices were 
calculated: crude and standardised rates of inci-
dence and mortality, stratum weights, cumulative 
risk of incidence and deaths and the proportion 
of lung cancer among malignant cancers. To cal-
culate crude rates, demographic tables prepared 
by the Central Statistical Office (Główny Urząd 
Statystyczny, GUS) were used. For standardised 
rates, “standard world population” was assumed 
as population, as proposed by Segi and modified 
by Doll. Statistical analysis was made using Mi-
crosoft Excell 2010. The maps were made with 
the help of the Map Viewer 7.
Results
Lung cancer incidence
The number of registered new cases of ma-
lignant lung cancer in total was equal to 886 in 
2011, and it was 14.9% lower than in 2002. In the 
discussed period, the decrease in incidence by 
22.4% in men was observed, and a simultaneous 
increase by 22.5% in first diagnosis in women 
was noted. 
In the analysed period, a significant decrease 
in crude and standardised rates of incidence 
in men was noticed. Crude rate amounted to 
83.9/100 000 in 2002, and to 64.7/100 000 in 2011. 
Whereas standardised rate was equal to 67.8/100 
000 in 2002, and 43.6/100 000 in 2011. While in 
the female population, incidence rate increased. 
Crude rate was 16.0/100 000 in 2002, and 19.5/100 
000 in 2011. Similarly dynamic were standardised 
incidence rates, in 2002 — 9.9/100 000, and in 
2011 — 11.8/100 000 (Fig. 2, Table 3).
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Figure 2. Lung cancer incidence in the Podkarpackie province 
between 2002−2011, standardised rates
Table 3. Registered new cancer cases and lung cancer incidence in the Podkarpackie province between 2002−2011
Incidence males Year Incidence females
Registered 
new can-
cer cases
Crude 
rate per 
100 000
Standardized 
rate
%Per-
centage
Cumu-
lative 
risk %
Cancer 
cases
Crude 
rate per  
100 000
Standardized 
rate
Percen-
tage
Cumu-
lative 
risk %
8018 − − − − 2002−2011 1975 − − − −
869 83.9 67.8 23.9 7.9 2002 173 16.0 9.9 5.7 1.1
778 75.5 59.9 20.4 7.5 2003 167 15.5 10.0 5.3 1.1
823 79.8 62.5 23.1 7.7 2004 157 14.6 8.8 5.3 1.1
813 78.9 59.6 21.3 7.5 2005 188 17.5 10.5 5.8 1.2
834 81.0 60.7 22.0 7.4 2006 203 18.9 10.9 6.1 1.3
867 84.2 60.6 23.1 7.4 2007 232 21.6 12.4 6.9 1.5
854 83.0 58.2 22.4 6.9 2008 216 20.1 11.3 6.2 1.4
811 78.7 54.7 20.7 6.7 2009 232 21.5 11.0 6.8 1.3
695 66.8 46.7 17.8 6.0 2010 195 18.0 10.2 5.6 1.2
674 64.7 43.6 17.7 5.7 2011 212 19.5 11.8 6.1 1.5
Figure 3. Lung cancer incidence by age groups in the Podkarpackie 
province between 2002−2011, males
Figure 4. Lung cancer incidence by age groups in the Podkarpackie 
province between 2002−2011, females
The proportion of malignant lung cancers 
among all cancers in men decreased by 6.2%, 
whereas in women it increased by 1.9%. In men, 
cumulative risk of incidence also decreased from 
7.9 in 2002 to 5.7 in 2011, and in women, it in-
creased from 1.1 in 2002 to 1.5 in 2011 (Table 3).
The highest incidence was observed in men 
aged 65+, both in 2002 and 2011. In the study 
group, the highest decrease in incidence was 
observed in 2011 (405.1/100 000), compared to 
2002 (495.1/100 000). The peak of incidence, in 
2002, occurred in the 9th decade of life, and in 
2011, in the 8th decade of life (Fig. 3).
In women, during the study period, the high-
est incidence rates were also found in the group 
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Figure 5. Lung cancer incidence in the Podkarpackie province be-
tween 2002−2011 by districts, males
Figure 6. Lung cancer incidence in the Podkarpackie province be-
tween 2002−2011 by districts, females
Table 4.  Lung cancer incidence in the Podkarpackie prov-
ince between 2002−2011 by districts, crude rate
District Incidence males Incidence females
bieszczadzki 64.3 27.3
brzozowski 84.3 15.2
dębicki 80.5 19.5
jarosławski 83.6 17.1
jasielski 78.8 17.9
kolbuszowski 83.8 9.6
krośnieński 81.1 14.9
leżajski 78.0 15.5
lubaczowski 93.1 15.0
łańcucki 65.8 11.7
mielecki 79.3 19.3
niżański 79.1 13.5
przemyski 82.0 22.1
przeworski 71.5 12.6
ropczycko- 
-sędziszowski
75.6 10.7
rzeszowski 70.5 12.8
sanocki 65.3 15.5
stalowowolski 78.3 20.7
strzyżowski 86.4 15.2
tarnobrzeski 71.0 16.7
leski 66.9 27.5
m. Krosno 71.8 26.5
m. Przemyśl 84.1 35.2
m. Rzeszów 66.8 24.1
m. Tarnobrzeg 75.5 25.1
aged 65+. In 2002, it amounted to 56.0/100 000, 
and in 2011, to 58.5/100 000. While in the male 
population, the decrease in incidence was visible 
in all discussed age groups; in the female popu-
lation, a slight decrease in incidence rates was 
noted in the group aged 20−44 years, whereas 
in the group aged 45−64 years, a considerable 
increase in incidence was observed (by 82.5%). 
During the analysis of peak of incidence in wom-
en in the years 2002 and 2011, it was found that 
the peak in 2011 occurred two decades earlier 
than in 2002 (Fig. 4).
While investigating the occurrence of lung 
cancer in the Podkarpackie province, incidence 
in particular districts was thoroughly analysed. 
In the Podkarpackie province, there is a huge di-
versity of incidence. In the discussed period, the 
highest incidence rates in men were noted in the 
lubaczowski district — 93.1/100 000, strzyżowski 
— 86.4/100 000, brzozowski — 84.3/100 000 and 
in the town of Przemyśl — 84.1/100 000. Whereas 
the lowest incidence was observed in the łańcuc-
ki district — 65.8/100 000, in the city of Rzeszów 
— 66.8/100 000, the leski district — 66.9/100 000 
and rzeszowski — 70.5/100 000. In women, the 
highest incidence was observed in the town of 
Przemyśl — 35.2/100 000, the leski district — 
27.5/100 000, bieszczadzki — 27.3/100 000 and 
in the town of Krosno — 26.5/100 000. The low-
est incidence was observed in the kolbuszowski 
district — 9.6/100 000, ropczycko-sędziszowski 
— 10.7/100 000, łańcucki — 11.7/100 000 and 
przeworski — 12.6/100 000 (Table 4, Figs 5, 6). 
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Deaths and mortality
The number of deaths due to malignant lung 
cancer in total amounted to 770 in 2011, and was by 
10.9% lower than in 2002. During the discussed pe-
riod, the decrease in the number of deaths by 16.6% 
in men was noted and a simultaneous increase in 
the number of deaths due to lung cancer by 21.5% 
in women was observed. In the study period, a sig-
nificant decrease in crude and standardised rates of 
mortality in men was noted. Crude rate was equal to 
70.9/100 000 in 2002, and to 58.8/100 000 in 2011. 
Whereas standardised rate amounted to 56.6/100 
000 in 2002, and to 38.7/100 000 in 2011.
On the other hand, in the female population, 
mortality rates increased. Crude rate was equal 
to 12.0/100 000 in 2002, and to 14.5/100 000 in 
2011. Standardised mortality rates also increased 
and they amounted to 7.5/100 000 in 2002, and 
to 8.0/100 000 in 2011. 
The proportion of deaths due to lung cancer 
among all cancer deaths in men decreased by 
5.1%, but in women it increased by 1.1%. Simi-
larly, cumulative risk in men decreased from 7.4 
in 2002 to 4.9 in 2011, whereas in women it in-
creased from 0.9 in 2002 to 1.0 in 2011 (Table 5).
The highest mortality due to malignant lung 
cancer in men in the Podkarpackie province in 
2002 and 2011 was noted in the group aged 65+. 
Mortality rates during this time were 461.1/100 
000 in 2002 and 349.4/100 000 in 2011. During 
the study period, a considerable decrease in mor-
tality was observed for the groups aged 45−64 
years and 65+. The peak of incidence in 2002 
occurred in the 8th decade of life, and in 2011, in 
the 9th decade of life (Fig. 7).
At the same time, in women, in the group 
aged 65+, the highest mortality rates were noted. 
They were equal to 49.0/100 000 in 2002, and to 
47.5/100 000 in 2011. While comparing selected 
age groups in men and women, the decrease in 
mortality in men in all age groups was observed, 
whereas in women, a slight decrease occurred 
Table 5. Deaths and lung cancer mortality in the Podkarpackie province between 2002−2011
Deaths males Year Deaths females
Cancer 
cases
Crude 
rate per 
100 000
Standardized 
rate
Percen-
tage
Cumulative 
risk
Cancer 
cases
Crude 
rate per 
100 000
Standardized 
rate
Percen-
tage
Cumulative 
risk %
7211 − − − − 2002-
2011
1571 − − − −
734 70.9 56.6 31.8 7.4 2002 130 12.0 7.5 8.6 0.9
734 71.2 55.7 30.9 7.0 2003 152 14.1 8.8 9.0 1.1
760 73.7 57.4 32.1 7.3 2004 139 12.9 7.7 8.7 0.9
738 71.6 54.2 31.1 7.0 2005 154 14.3 8.7 9.1 1.0
707 68.6 50.7 29.0 6.4 2006 148 13.8 7.4 8.5 0.9
760 73.8 53.4 30.4 6.7 2007 162 15.0 8.7 9.4 1.0
739 71.8 49.8 29.5 6.2 2008 185 17.2 9.3 10.6 1.2
738 71.6 48.6 28.8 5.9 2009 175 16.2 8.2 9.7 1.0
689 66.2 45.2 29.6 5.7 2010 168 15.6 8.7 10.5 1.1
612 58.8 38.7 26.7 4.9 2011 158 14.5 8.0 9.7 1.0
Figure 7. Lung cancer mortality by age groups in the Podkarpackie 
province between 2002−2011, males
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Figure 10. Lung cancer mortality in the Podkarpackie province be-
tween 2002−2011 by districts, females
Figure 9. Lung cancer mortality in the Podkarpackie province between 
2002−2011 by districts, males
Figure 8. Lung cancer mortality by age groups in the Podkarpackie 
province between 2002−2011, females
Table 6.  Lung cancer mortality in the Podkarpackie prov-
ince by districts, crude rate per 100 000 persons
District Mortality males Mortality females
bieszczadzki 75.9 22.9
brzozowski 76.3 13.1
dębicki 66.6 10.5
jarosławski 71.6 16.3
jasielski 78.6 14.4
kolbuszowski 70.2 6.1
krośnieński 71.7 11.5
leżajski 67.8 13.0
lubaczowski 82.8 12.6
łańcucki 60.3 9.2
mielecki 70.9 16.8
niżański 65.1 10.6
przemyski 77.6 15.4
przeworski 70.7 13.3
ropczycko-sędzi-
szowski
66.3 8.0
rzeszowski 67.6 9.5
sanocki 67.0 15.5
stalowowolski 74.2 15.9
strzyżowski 81.5 16.1
tarnobrzeski 69.5 11.6
leski 61.6 25.3
m. Krosno 59.6 22.1
m. Przemyśl 73.9 29.0
m. Rzeszów 59.2 20.4
m. Tarnobrzeg 65.5 19.3
in the groups aged 20−44 and 65+, whereas in 
the group aged 45−64 a considerable increase 
in mortality was noted (by 53.1%). In 2002, the 
increase in mortality occurred in the 6th and 8th 
decade of life, and in 2011, the height of mortality 
occurred in the 7th and 8th decade (Fig. 8).
In the Podkarpackie province, a high diver-
sity of mortality due to lung cancer in particular 
districts is observed. In the years 2002−2011, the 
highest mortality rates in men were noted in the 
lubaczowski district — 82.8/100 000, strzyżows-
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2002−2011 had a downward tendency, and the 
rates for the examined province for the analysed 
period were considerably lower, compared to 
the rates for Poland. Similar was the situation in 
women. Mortality rates for the analysed period 
of time in women living in the Podkarpackie 
province were considerably lower, compared to 
the rates for Poland.
In Poland, there is a great diversity of inci-
dence and mortality between men and women. 
The highest incidence in men in 2011 was noted 
in the Świętokrzyskie province and the lowest in 
Podlasie. In as many as 10 provinces of Poland, 
incidence rates were higher than the mean for 
the country. In women, the highest incidence 
occurred in the Łódź province and it was twice as 
high as in the Podkarpackie province. The latter 
also had the lowest mortality rate for men and 
women in Poland. Whereas the highest rates were 
found in men in the Mazowieckie province, and 
in women in the Pomorskie province (Table 8). 
According to the forecast concerning mortali-
ty from malignant lung cancer in Poland, mortali-
ty among men aged 35+ and 35−69 will decrease 
by 2025, while it will increase permanently in 
the oldest group aged 70+. In women, an upward 
tendency has been foreseen in all age groups 
[18]. Despite the decrease in standardised mor-
tality rates, the number of deaths will grow. The 
decrease in deaths by approximately 12.5% has 
been foreseen solely in men aged 35−69 years. 
The highest increase in deaths count has been 
foreseen for the oldest group aged 70+ (119.4% 
in men, and 110.2% in women) [18].
Poland is one of the countries with the high-
est rates (33.43/100 000). The lowest incidence 
was observed in Germany (22.16/100 000), where 
standardised rate was twice as high as in Hungary 
(43.32/100 000). The lowest mortality rates were 
found in Slovakia, Czech Republic and Germany, 
whereas a considerably high standardised rate 
was noted in Hungary (Table 9).
In EUROCARE-5 (concerning the patients 
diagnosed between the years 2000−2007), a 
5-year relative survival for Poland was 14.25% 
(Table 9). According to the analysis of patients 
diagnosed between 2003−2005 prepared by 
the National Cancer Register, the proportion of 
5-year relative survivals in Poland was 11.9% 
for men and 16.9% for women [20]. The pro-
portion of survival for men in the Podkarpackie 
province was equal to that for Poland, whereas 
in women, the rates were higher by 3%, com-
pared to the rate for Poland (patients diagnosed 
between 2000−2002) [21]. 
ki — 81.5/100 000, jasielski — 78.6/100 000 and 
przemyski — 77.6/100 000. Whereas the lowest 
mortality was observed in the city of Rzeszów 
— 59.2/100 000, the town of Krosno — 59.6/100 
000, the łańcucki district 6.3/100 000 and leski 
district — 61.6/100 000. In women, the highest 
mortality was found in the town of Przemyśl — 
29.0/100 000, the leski district — 25.3/100 000, 
bieszczadzki — 22.9/100 000, and in the town of 
Krosno — 22.1/100 000. The lowest mortality was 
noted in the kolbuszowski district — 6.1/100 000, 
ropczycko-sędziszowski — 8.0/100 000, łańcuc-
ki — 9.2/100 000 and rzeszowski — 9.5/100 000 
(Table 6, Figs 9, 10).
Discussion
Between the years 1970−1974, in Poland, 
deaths due to lung cancer constituted approxi-
mately 25% of all cancer deaths in men and 5% 
in women. The lowest incidence rates at that 
time were observed in the eastern provinces [17]. 
During the following two decades, a dynamic 
growth in the mortality rate in both sexes has 
been noted. Stability and a slow decrease in 
mortality in men did not occur until the end of 
the 1990s [6].
While comparing the structure of incidence 
and deaths in men in Poland and in the Podkar-
packie province in 2011, lung cancer was taking 
the first place. Whereas among women in Poland, 
it was taking the second place, and in the Podkar-
packie province — it was on the fifth position. But 
taking into account the structure of deaths among 
women in Poland, lung cancer took the first place, 
and in the Podkarpackie province — the third one.
In Poland and in the Podkarpackie province, 
a considerable fall in incidence rates among men 
has been observed. Between the years 2002−2011, 
in men, standardised incidence rates were equal 
to 63.0/100 000 for Poland and 64.4/100 000 for 
the Podkarpackie province in 2002, and 50.0/100 
000 for Poland and 43.6/100 000 for the Podkar-
packie province in 2011. In the discussed period, 
standardised rates in the years 2002, 2006−2009 
in the Podkarpackie province reached higher 
values, compared to those for Poland. Whereas in 
women, during the study period, a considerable 
growth in mortality occurred, both in Poland and 
in the Podkarpackie province. However, during 
the discussed period, standardised rates for Po-
land took higher values than the coefficients for 
the Podkarpackie province. 
Mortality due to lung cancer in men, in 
Poland and the Podkarpackie province between 
Pneumonologia i Alergologia Polska 2015, vol. 83, no. 2, pages 109–119 
118 www.pneumonologia.viamedica.pl
In 2006, a population study using a ques-
tionnaire was conducted in 16 provinces. Its 
objective was to evaluate the knowledge and 
attitude of about 8000 Poles towards healthy 
lifestyle rules included in the European Code 
Against Cancer. 78.4% of respondents believed 
that they took care of their health. The most vital 
factor of lung cancer incidence is tobacco smok-
Table 8. Lung cancer incidence and mortality in Poland by provinces, 2011 [4]
Province Incidence 
males
Province Incidence 
females
Province Mortality 
males
Province Mortality 
females
Podlaskie 56.59 Podkarpackie 19.52 Podkarpackie 58.76 Podkarpackie 14.55
Lubuskie 63.62 Podlaskie 19.66 Małopolskie 74.19 Małopolskie 22.27
Podkarpackie 64.71 Małopolskie 22.86 Opolskie 75.15 Lubelskie 22.94
Małopolskie 67.22 Lubelskie 23.12 Podlaskie 80.97 Świętokrzyskie 26.26
Zachodniopomorskie 71.57 Świętokrzyskie 26.57 Wielkopolskie 81.27 Podlaskie 27.63
Mazowieckie 73.00 Mazowieckie 29.31 Polska 85.58 Opolskie 28.98
Polska 77.87 Lubuskie 30.30 Lubelskie 86.30 Polska 31.47
Wielkopolskie 78.41 Polska 31.61 Śląskie 86.50 Śląskie 31.70
Opolskie 80.45 Wielkopolskie 31.77 Zachodniopomorskie 88.12 Wielkopolskie 33.13
Lubelskie 80.70 Opolskie 32.22 Kujawsko- 
-Pomorskie
88.70 Lubuskie 35.06
Śląskie 81.13 Śląskie 33.58 Dolnośląskie 88.76 Łódzkie 35.10
Dolnośląskie 83.84 Zachodniopomorskie 36.79 Lubuskie 89.51 Kujawsko- 
-Pomorskie
35.33
Łódzkie 84.40 Kujawsko- 
-Pomorskie
38.01 Pomorskie 89.87 Mazowieckie 35.90
Pomorskie 85.28 Dolnośląskie 38.46 Świętokrzyskie 89.89 Dolnośląskie 36.22
Kujawsko- 
-Pomorskie
89.09 Pomorskie 39.48 Warmińsko- 
Mazurskie
91.17 Zachodniopomorskie 36.57
Warmińsko- 
-Mazurskie
91.74 Warmińsko- 
-Mazurskie
39.80 Łódzkie 91.67 Warmińsko- 
-Mazurskie
37.37
Świętokrzyskie 93.57 Łódzkie 41.35 Mazowieckie 96.73 Pomorskie 38.54
Table 9.  Lung cancer incidence and mortality in the selected European countries, 2012, standardised rates, a 5-year  
relative survival by cancer [3, 19]
Country Incidence Mortality 5-year relative survival
EUROCARE-5 (2000−2007)
Spain 22.78 30.30 10.61
France 25.33 34.95 14.28
Belgium 30.51 36.81 14.63
Germany 22.16 27.51 15.61
Poland 33.43 38.03 14.25
Hungary 43.32 51.60 has not participated in the study
Romania 27.60 32.56 has not participated in the study
Serbia 39.06 45.57 has not participated in the study
Great Britain 25.36 29.95 7.41
Slovakia 28.27 21.60 10.33
Czech Republic 32.45 24.70 11.31
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ing. The results of the study has shown that men 
smoked more frequently than women, apart from 
the oldest age group (60+), and that the number 
of smokers is increasing together with age. The 
highest proportion of smokers occurred in the 
Lower Silesia province (39.1%) and the Kuiavian- 
-Pomeranian and Opole provinces (36.3%), where-
as the smallest was observed in the Podkarpackie 
province (23%). In the Podkarpackie province, 
a considerable proportion of the study subjects 
reported to have been never smokers (61.8%). 
The conclusions drawn from the study suggest 
that preventive programs should be addressed 
to poorer and less educated social groups, on 
the other hand, the provinces of Poland with the 
highest incidence rate need more individualised 
preventive programs [22].
Conclusions
1.  In 2011, in the Podkarpackie province, the 
number of lung cancer incidence in men de-
creased by 22.4%, compared to 2002, whereas 
in women, it increased by 22.5%.
2.  During the study period, the decrease in mor-
tality due to lung cancer by 16.6% occurred, 
and a simultaneous increase in mortality in 
women by 21.45% was observed.
3.  In the districts of the Podkarpackie province, 
between 2002−2011, the highest incidence 
rate was noted in the lubaczowski district, 
and the lowest in the kolbuszowski district, 
while the highest mortality rate was found 
in the lubaczowski district, and the lowest 
in the city of Rzeszów.
4.  In the districts of the Podkarpackie province, 
between 2002−2011, the highest incidence 
rate for women was observed in the town of 
Przemyśl, and the lowest in the kolbuszowski 
district, whereas the highest mortality rate 
was found in the town of Przemyśl, and the 
lowest in the kolbuszowski district.
5.  It is recommended to strengthen appropriate 
healthy lifestyle patterns and to protect he-
althy people, particularly women, children 
and young people from disadvantageous 
conduct.
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